BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27401045)

  • 1. Closed-Loop Deep Brain Stimulation Effects on Parkinsonian Motor Symptoms in a Non-Human Primate - Is Beta Enough?
    Johnson LA; Nebeck SD; Muralidharan A; Johnson MD; Baker KB; Vitek JL
    Brain Stimul; 2016; 9(6):892-896. PubMed ID: 27401045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinated Reset Deep Brain Stimulation of Subthalamic Nucleus Produces Long-Lasting, Dose-Dependent Motor Improvements in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Non-Human Primate Model of Parkinsonism.
    Wang J; Nebeck S; Muralidharan A; Johnson MD; Vitek JL; Baker KB
    Brain Stimul; 2016; 9(4):609-17. PubMed ID: 27151601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sixty-hertz stimulation improves bradykinesia and amplifies subthalamic low-frequency oscillations.
    Blumenfeld Z; Koop MM; Prieto TE; Shreve LA; Velisar A; Quinn EJ; Trager MH; Brontë-Stewart H
    Mov Disord; 2017 Jan; 32(1):80-88. PubMed ID: 27859579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local field potential activity dynamics in response to deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Wiest C; Tinkhauser G; Pogosyan A; Bange M; Muthuraman M; Groppa S; Baig F; Mostofi A; Pereira EA; Tan H; Brown P; Torrecillos F
    Neurobiol Dis; 2020 Sep; 143():105019. PubMed ID: 32681881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinsonian Beta Dynamics during Rest and Movement in the Dorsal Pallidum and Subthalamic Nucleus.
    Eisinger RS; Cagle JN; Opri E; Alcantara J; Cernera S; Foote KD; Okun MS; Gunduz A
    J Neurosci; 2020 Apr; 40(14):2859-2867. PubMed ID: 32107277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.
    Trager MH; Koop MM; Velisar A; Blumenfeld Z; Nikolau JS; Quinn EJ; Martin T; Bronte-Stewart H
    Neurobiol Dis; 2016 Dec; 96():22-30. PubMed ID: 27553876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On-Off and Proportional Closed-Loop Adaptive Deep Brain Stimulation Reduces Motor Symptoms in Freely Moving Hemiparkinsonian Rats.
    Evers J; Orłowski J; Jahns H; Lowery MM
    Neuromodulation; 2024 Apr; 27(3):476-488. PubMed ID: 37245140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution local field potentials measured with deep brain stimulation arrays.
    Zhang S; Connolly AT; Madden LR; Vitek JL; Johnson MD
    J Neural Eng; 2018 Aug; 15(4):046019. PubMed ID: 29651998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency-Specific Optogenetic Deep Brain Stimulation of Subthalamic Nucleus Improves Parkinsonian Motor Behaviors.
    Yu C; Cassar IR; Sambangi J; Grill WM
    J Neurosci; 2020 May; 40(22):4323-4334. PubMed ID: 32312888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromodulation targets pathological not physiological beta bursts during gait in Parkinson's disease.
    Anidi C; O'Day JJ; Anderson RW; Afzal MF; Syrkin-Nikolau J; Velisar A; Bronte-Stewart HM
    Neurobiol Dis; 2018 Dec; 120():107-117. PubMed ID: 30196050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced target identification in STN-DBS with beta power of combined local field potentials and spiking activity.
    Verhagen R; Zwartjes DG; Heida T; Wiegers EC; Contarino MF; de Bie RM; van den Munckhof P; Schuurman PR; Veltink PH; Bour LJ
    J Neurosci Methods; 2015 Sep; 253():116-25. PubMed ID: 26079495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sequence Effect Worsens Over Time in Parkinson's Disease and Responds to Open and Closed-Loop Subthalamic Nucleus Deep Brain Stimulation.
    Kehnemouyi YM; Petrucci MN; Wilkins KB; Melbourne JA; Bronte-Stewart HM
    J Parkinsons Dis; 2023; 13(4):537-548. PubMed ID: 37125563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of beta bursts in subthalamic sensorimotor circuits predicts improvement in bradykinesia.
    Kehnemouyi YM; Wilkins KB; Anidi CM; Anderson RW; Afzal MF; Bronte-Stewart HM
    Brain; 2021 Mar; 144(2):473-486. PubMed ID: 33301569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Unilateral Subthalamic Nucleus Deep Brain Stimulation on Contralateral Subthalamic Nucleus Local Field Potentials.
    Hasegawa H; Fischer P; Tan H; Pogosyan A; Samuel M; Brown P; Ashkan K
    Neuromodulation; 2020 Jun; 23(4):509-514. PubMed ID: 32281215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectral Topography of the Subthalamic Nucleus to Inform Next-Generation Deep Brain Stimulation.
    Averna A; Debove I; Nowacki A; Peterman K; Duchet B; Sousa M; Bernasconi E; Alva L; Lachenmayer ML; Schuepbach M; Pollo C; Krack P; Nguyen TK; Tinkhauser G
    Mov Disord; 2023 May; 38(5):818-830. PubMed ID: 36987385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parkinsonism and vigilance: alteration in neural oscillatory activity and phase-amplitude coupling in the basal ganglia and motor cortex.
    Escobar Sanabria D; Johnson LA; Nebeck SD; Zhang J; Johnson MD; Baker KB; Molnar GF; Vitek JL
    J Neurophysiol; 2017 Nov; 118(5):2654-2669. PubMed ID: 28835526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic local field beta oscillations during ongoing deep brain stimulation in Parkinson's disease in hyperacute and chronic phases.
    Rosa M; Giannicola G; Servello D; Marceglia S; Pacchetti C; Porta M; Sassi M; Scelzo E; Barbieri S; Priori A
    Neurosignals; 2011; 19(3):151-62. PubMed ID: 21757872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
    Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.